Embarrassing Illnesses

Alamanos, A., Tsifetaki, N., Voulgari, P.V., Venetsanopoulou, I.V., Siozos, C., Drosos, A.A., (2006). Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology. Oxford:Feb 1, 2006. Vol. 45, Iss. 2, p. 187

Aquavella, J.V., Williams, Z. (2008). Sjogren syndrome. eMedicine.com
avaiable online at: http://www.emedicine.com/oph/topic477.htm

British Sjogren's Syndrome Association (2003). A Concise Guide To Diagnosis And Management For Health Professionals

Brito-Zerón, P., Ramos-Casals, M., Bove, A., Sentis, J., Font, J (2007). Rheumatology. Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Oxford:Aug 2007. Vol. 46, Iss. 8, p. 1359-1362 (4 pp.)

Davidson, A., Diamond, B. (2001). Autoimmune diseases. The New England Journal of Medicine, 345(5), 340-350.

Fox., R.I. (2005).Sjögren's syndrome. The Lancet. London:Jul 23-Jul 29, 2005. Vol. 366, Iss. 9482, p. 321-31 (11 pp.)

Gibson, J., Halliday, J.A., Ewert, K., Robertson, S. (2007). A controlled release pilocarpine buccal insert in the treatment of Sjögren's syndrome. British Dental Journal, 202(7), E17; discussion 404-5.

Goransson, L.G. et al (2006). Peripheral Neuropathy in Primary Sjogren Syndrome: A Population-Based Study. Arch Neurol. 2006;63(11):1612-1615.

Kassan, S.K., Moutsopoulos, H.M. (2004). Clinical Manifestations and Early Diagnosis of Sjogren Syndrome. Arch Intern Med. 2004;164(12):1275-1284.

Lafitte, C. (2000). Neurological Manifestations in Sjogren Syndrome. Arch Neurol. 2000;57(3):411-413.

Lazarus, M.N., Robinson, D., Mak, V., Møller,H., Isenberg, D.A. (2006). Incidence of cancer in a cohort of patients with primary Sjögren's syndrome. Rheumatology. Oxford:Aug 2006. Vol. 45, Iss. 8, p. 1012

Mathews,S.A., Kurien, B.T., Scofield, R.H.(2008).Oral Manifestations of Sjögren's Syndrome . Journal of Dental Research. Houston:Apr 2008. Vol. 87, Iss. 4, p. 308-18 (11 pp.)

Ramos-Casals, M., J. Font, J.(2005). Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology. Oxford:Nov 15, 2005. Vol. 44, Iss. 11, p. 1354

Thomas, E., Hay, E.M., Hajeer, A, Silman, A.J. (1998). Sjogren's syndrome: a community-based study of prevalence and impact Rheumatology 37: 1069-1076.

Versura, P., Frigato, M., Cellini, M., Mulè, R., Malavolta, N., Campos, E.C. (2007).Diagnostic performance of tear function tests in Sjogren's syndrome patients. Eye. London:Feb 2007. Vol. 21, Iss. 2, p. 229-37 (9 pp.)

Zintzaras, E. et al (2005). The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis. Arch Intern Med. 2005;165(20):2337-2344.